Academics
follow us
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • Instagram
Feedback
Patent Number:- IN407183

Larvicidal Formulation and a Process for the Preparation Thereof

  • Sector: Biotechnology,
  • IPC: A01N, F21K, G01V,
 

Need

There is a need for an effective, quick-acting, and non-toxic larvicidal formulation to control mosquitoes and vector-borne diseases, overcoming drawbacks of prior art.

Solution

The present invention offers a larvicidal formulation with 100% larvicidal activity against various mosquito larvae.

Innovation

The formulation combines specific concentrations of plant extracts, including hexane extract of Piper nigrum fruits, water extract of Camellia sinensis, and water extract of Moringa oleifera, providing effective larvicidal activity against multiple mosquito species.

Market Analysis

Market: Vector control, larvicidal formulations

CAGR: Approximately 5-7%

Potential Indian Clients: Government health departments, NGOs, pharmaceutical companies

Why Invest?


Larvicidal

Vector-borne diseases

Non-toxic

Biological Control

At a Glance


Current TRL: NA

Funded by: NA

IPC: A01N, F21K, G01V

Domain: Public Health, Biotechnology

For more information, reach out to Mr. Rajneesh Kumar, Head of the Technology Transfer Office, at tto@bits-pilani.ac.in and 01596-255515.